# Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

> **NCT00524017** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 35 (actual)

## Conditions studied

- Head and Neck Cancer
- Precancerous Condition

## Interventions

- **BIOLOGICAL:** cetuximab

## Key facts

- **NCT ID:** NCT00524017
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524017, "Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00524017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*